Zoledronic Acid Is Superior to Pamidronate in the Treatment of Hypercalcemia of Malignancy: A Pooled Analysis of Two Randomized, Controlled Clinical Trials - Concepedia

Concepedia

Publication | Closed Access

Zoledronic Acid Is Superior to Pamidronate in the Treatment of Hypercalcemia of Malignancy: A Pooled Analysis of Two Randomized, Controlled Clinical Trials

851

Citations

25

References

2001

Year

Pierre Major, Alain Lortholary, Jeremy K. Hon, Ehtesham Abdi, Glenn Mills, H. D. Menssen, F. Yunus, R. Bell, J.J. Body, Erhard Quebe‐Fehling,

Journal of Clinical Oncology

Abstract

Zoledronic acid is superior to pamidronate; 4 mg is the dose recommended for initial treatment of HCM and 8 mg for relapsed or refractory hypercalcemia.

References

	Year	Citations

Page 1